Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 60/100

Palatin to Report Third Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on

Key Takeaway: Palatin Technologies, Inc. will announce its third quarter fiscal results on May 16, 2023. A conference call and audio webcast will follow, allowing executives to review performance and provide updates on ongoing developmental programs. The company focuses on creating innovative therapies aimed at addressing significant medical needs and aims to capitalize on its developments through strategic partnerships.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palatin will report its third quarter fiscal year 2023 results, indicating ongoing business activity.
  • The company is developing first-in-class medicines for significant unmet medical needs, showing potential for innovation.
  • Palatin's strategy includes forming marketing collaborations with industry leaders, which could enhance commercial success.

Full Press Release Details

ptn_ex991.htm EXHIBIT 99.1
Palatin to Report Third Quarter Fiscal Year 2023 Results;
Teleconference and Webcast to be held on May 16, 2023
CRANBURY, N.J., May 11, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter fiscal year 2023 operating results on Tuesday, May 16, 2023, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 16, 2023, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q3 Fiscal Year 2023 Results Press Release 05/16/2023 at 7:30 a.m. ET
Q3 Fiscal Year 2023 Conference Call-Live 05/16/2023 at 11:00 a.m. ET
US Toll Free Dial-In Number: 1-888-506-0062
International Dial-In Number: 1-973-528-0011
Participant Access Code: 555988
Q3 Fiscal Year 2023 Conference Call-Replay 05/16/2023-05/30/2023
US Toll Free Dial-In Number: 1-877-481-4010
International Dial-In Number: 1-919-882-2331
Participant Access Code: 48459
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by accessing this link.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
Palatin Investor Inquiries: Palatin Media Inquiries:
Stephen T. Wills, CPA, MST Paul Arndt, MBA, LifeSci Advisors, LLC
Chief Operating Officer / Chief Financial Officer Managing Director
Tel: (609) 495-2200 / info@palatin.com Tel: (646) 597-6992 / Paul@LifeSciAdvisors.com

Frequently Asked Questions

When will Palatin report its Q3 fiscal year 2023 results?

Palatin will report its Q3 fiscal year 2023 results on May 16, 2023.

What time is Palatin's Q3 conference call?

The conference call will take place at 11:00 a.m. ET on May 16, 2023.

How can I access the Palatin conference call replay?

The replay can be accessed from May 16 to May 30, 2023, using provided numbers.

What is Palatin Technologies focused on developing?

Palatin develops first-in-class medicines targeting melanocortin receptor systems.

Who should I contact for investor inquiries at Palatin?

Contact Stephen T. Wills for investor inquiries via phone or email provided.

Last updated: May 12, 2023